Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-054417
Filing Date
2018-02-23
Accepted
2018-02-22 18:13:17
Documents
10
Period of Report
2018-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d510639d6k.htm 6-K 9156
2 EX-99.1 d510639dex991.htm EX-99.1 424698
3 GRAPHIC g51063911snap0001.jpg GRAPHIC 2178
4 GRAPHIC g510639g0222144505898.jpg GRAPHIC 3934
5 GRAPHIC g510639g0222152954222.jpg GRAPHIC 3934
6 GRAPHIC g510639g0222152954534.jpg GRAPHIC 2273
7 GRAPHIC g510639g34j38.jpg GRAPHIC 2980
8 GRAPHIC g510639g74c77.jpg GRAPHIC 2902
9 GRAPHIC g510639snap0002.jpg GRAPHIC 2780
10 GRAPHIC g510639snap0003.jpg GRAPHIC 2556
  Complete submission text file 0001193125-18-054417.txt   468601
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 18633942
SIC: 2834 Pharmaceutical Preparations